Paracrine effect of transplanted rib chondrocyte spheroids supports formation of secondary cartilage repair tissue†
Corresponding Author
Kolja Gelse
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany
Department of Orthopaedic Rheumatology, University of Erlangen-Nuernberg, Germany
Interdisciplinary Center for Clinical Research, University Hospital Erlangen, Germany
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany T: 0049-9131-8542121; F: 0049-9131-8533300.Search for more papers by this authorMatthias Brem
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany
Search for more papers by this authorPatricia Klinger
Department of Orthopaedic Rheumatology, University of Erlangen-Nuernberg, Germany
Interdisciplinary Center for Clinical Research, University Hospital Erlangen, Germany
Search for more papers by this authorAndreas Hess
Institute of Pharmacology and Toxicology, University of Erlangen-Nuernberg, Germany
Search for more papers by this authorBernd Swoboda
Department of Orthopaedic Rheumatology, University of Erlangen-Nuernberg, Germany
Search for more papers by this authorFriedrich Hennig
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany
Search for more papers by this authorAlexander Olk
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany
Search for more papers by this authorCorresponding Author
Kolja Gelse
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany
Department of Orthopaedic Rheumatology, University of Erlangen-Nuernberg, Germany
Interdisciplinary Center for Clinical Research, University Hospital Erlangen, Germany
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany T: 0049-9131-8542121; F: 0049-9131-8533300.Search for more papers by this authorMatthias Brem
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany
Search for more papers by this authorPatricia Klinger
Department of Orthopaedic Rheumatology, University of Erlangen-Nuernberg, Germany
Interdisciplinary Center for Clinical Research, University Hospital Erlangen, Germany
Search for more papers by this authorAndreas Hess
Institute of Pharmacology and Toxicology, University of Erlangen-Nuernberg, Germany
Search for more papers by this authorBernd Swoboda
Department of Orthopaedic Rheumatology, University of Erlangen-Nuernberg, Germany
Search for more papers by this authorFriedrich Hennig
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany
Search for more papers by this authorAlexander Olk
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstr. 12, 91054 Erlangen, Germany
Search for more papers by this authorK. Gelse and M. Brem contributed equally to this work.
Abstract
The study's objective was to investigate if transplanted chondrocyte or periosteal cell spheroids have influence on ingrowing bone marrow-derived cells in a novel cartilage repair approach in miniature pigs. Autologous rib chondrocytes or periosteal cells were cultured as spheroids and press-fitted into cavities that were milled into large, superficial chondral lesions of the patellar joint surface. Within the milled cavities, the subchondral bone plate was either penetrated or left intact (full-thickness or partial-thickness cavities). The transplantation of chondrocyte spheroids into full-thickness cavities induced the formation of additional secondary repair cartilage that exceeded the original volume of the transplanted spheroids. The resulting continuous tissue was rich in proteoglycans and stained positive for type II collagen. Cell labeling revealed that secondarily invading repair cells did not originate from transplanted spheroids, but rather from arroded bone marrow. However, secondary invasion of repair cells was less pronounced following transplantation of periosteal cells and absent in partial-thickness cavities. According to in vitro analyses, these observations could be ascribed to the ability of chondrocyte spheroids to secrete relevant amounts of bone morphogenetic protein-2, which was not detected for periosteal cells. Transplanted chondrocyte spheroids exert a dual function: they provide cells for the repair tissue and have a stimulatory paracrine activity, which promotes ingrowth and chondrogenesis of bone marrow-derived cells. © 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res
Supporting Information
Additional Supporting Information may be found in the online version of this article.
Filename | Description |
---|---|
jor_20874_sm_SupplFig1.tif1.6 MB | Supplementry Figure 1 |
jor_20874_sm_SupplFig2.tif24.9 MB | Supplementry Figure 2 |
jor_20874_sm_SupplFig3.tif24.9 MB | Supplementry Figure 3 |
jor_20874_sm_SupplFig4.tif24.8 MB | Supplementry Figure 4 |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1 Park J, Gelse K, Frank S, et al. 2006. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells. J Gene Med 8: 112–125.
- 2 Winter A, Breit S, Parsch D, et al. 2003. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum 48: 418–429.
- 3 De Bari C, Dell'Accio F, Tylzanowski P, et al. 2001. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44: 1928–1942.
- 4 Adachi N, Sato K, Usas A, et al. 2002. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol 29: 1920–1930.
- 5 Franke O, Durst K, Maier V, et al. 2007. Mechanical properties of hyaline and repair cartilage studied by nanoindentation. Acta Biomater 3: 873–881.
- 6 Knutsen G, Engebretsen L, Ludvigsen TC, et al. 2004. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg [Am] 86-A: 455–464.
- 7 Saris DB, Vanlauwe J, Victor J, et al. 2008. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med 36: 235–246.
- 8 Breinan HA, Martin SD, Hsu HP, et al. 2000. Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes. J Orthop Res 18: 781–789.
- 9 Shapiro F, Koide S, Glimcher MJ. 1993. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg [Am] 75: 532–553.
- 10 De Bari C, Dell'Accio F, Luyten FP. 2004. Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum 50: 142–150.
- 11 Gelse K, von der Mark K, Aigner T, et al. 2003. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum 48: 430–441.
- 12 Gelse K, Muhle C, Franke O, et al. 2008. Cell-based resurfacing of large cartilage defects: long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis. Arthritis Rheum 58: 475–488.
- 13 Briggs TW, Mahroof S, David LA, et al. 2003. Histological evaluation of chondral defects after autologous chondrocyte implantation of the knee. J Bone Joint Surg [Br] 85: 1077–1083.
- 14 Gigante A, Bevilacqua C, Zara C, et al. 2001. Autologous chondrocyte implantation: cells phenotype and proliferation analysis. Knee Surg Sports Traumatol Arthrosc 9: 254–258.
- 15 Shakibaei M, Csaki C, Rahmanzadeh M, et al. 2008. Interaction between human chondrocytes and extracellular matrix in vitro: a contribution to autologous chondrocyte transplantation. Orthopade 37: 440–447.
- 16 Takagi M, Umetsu Y, Fujiwara M, et al. 2007. High inoculation cell density could accelerate the differentiation of human bone marrow mesenchymal stem cells to chondrocyte cells. J Biosci Bioeng 103: 98–100.
- 17 Kuettner KE, Memoli VA, Pauli BU, et al. 1982. Synthesis of cartilage matrix by mammalian chondrocytes in vitro. II. Maintenance of collagen and proteoglycan phenotype. J Cell Biol 93: 751–757.
- 18 Grimmer C, Balbus N, Lang U, et al. 2006. Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: possible influence of low oxygen levels. Am J Pathol 169: 491–502.
- 19 Mainil-Varlet P, Aigner T, Brittberg M, et al. 2003. Histological assessment of cartilage repair: a report by the Histology Endpoint Committee of the International Cartilage Repair Society (ICRS). J Bone Joint Surg [Am] 85- (Suppl 2): 45–57.
- 20 Goldring MB, Tsuchimochi K, Ijiri K. 2006. The control of chondrogenesis. J Cell Biochem 97: 33–44.
- 21 Brittberg M, Sjogren-Jansson E, Thornemo M, et al. 2005. Clonal growth of human articular cartilage and the functional role of the periosteum in chondrogenesis. Osteoarthritis Cartilage 13: 146–153.
- 22 Kieswetter K, Schwartz Z, Alderete M, et al. 1997. Platelet derived growth factor stimulates chondrocyte proliferation but prevents endochondral maturation. Endocrine 6: 257–264.
- 23 Ataliotis P. 2000. Platelet-derived growth factor A modulates limb chondrogenesis both in vivo and in vitro. Mech Dev 94: 13–24.
- 24 Denker AE, Haas AR, Nicoll SB, et al. 1999. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differentiation 64: 67–76.
- 25 Schmidmaier G, Herrmann S, Green J, et al. 2006. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. Bone 39: 1156–1163.
- 26 Sengle G, Charbonneau NL, Ono RN, et al. 2008. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J Biol Chem 283: 13874–13888.
- 27 Hwang NS, Varghese S, Puleo C, et al. 2007. Morphogenetic signals from chondrocytes promote chondrogenic and osteogenic differentiation of mesenchymal stem cells. J Cell Physiol 212: 281–284.
- 28 Ponte AL, Marais E, Gallay N, et al. 2007. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737–1745.
- 29 Ozaki Y, Nishimura M, Sekiya K, et al. 2007. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev 16: 119–129.
- 30 Mishima Y, Lotz M. 2008. Chemotaxis of human articular chondrocytes and mesenchymal stem cells. J Orthop Res 26: 1407–1412.
- 31 Giannoudis PV, Pountos I, Morley J, et al. 2008. Growth factor release following femoral nailing. Bone 42: 751–757.
- 32 Isogai N, Kusuhara H, Ikada Y, et al. 2006. Comparison of different chondrocytes for use in tissue engineering of cartilage model structures. Tissue Eng 12: 691–703.
- 33 Xu JW, Zaporojan V, Peretti GM, et al. 2004. Injectable tissue-engineered cartilage with different chondrocyte sources. Plast Reconstr Surg 113: 1361–1371.